This year’s Nobel Prizes rewarded work done towards developing new treatments, to combat the use of sexual violence as a weapon of war, and in medical research. Talha Burki reports.
1138
This year’s Nobel Prizes rewarded work done towards developing new treatments, to combat the use of sexual violence as a weapon of war, and in medical research. Talha Burki reports.
Peter MacCallum Cancer Centre’s five Victorian sites have deployed a unified radiotherapy treatment planning and oncology informatic system.
In a partnership with research and developers Varian, the Peter Mac hospital locations will have new cloud-hosted treatment planning systems, as well as new oncology imaging informatics systems.
Nilgun Touma, Director of Radiation Therapy Services at Peter Mac, Melbourne, said the new systems will support the radiation oncology team to develop tailored treatment regimens – a task that requires absolute confidence in the accuracy of patient data and efficiency of planning workflows.
Until recently, Peter Mac ran multiple treatment planning systems across its five radiation therapy sites.
Along with the rising global burden of disability attributed to stroke, costs of stroke care are rising, providing the impetus to direct our research focus towards effective measures of stroke prevention. In this Series paper, we discuss strategies for reducing the risk of the emergence of disease (primordial prevention), preventing the onset of disease (primary prevention), and preventing the recurrence of disease (secondary prevention). Our focus includes global strategies and campaigns, and measurements of the effectiveness of worldwide preventive interventions, with an emphasis on low-income and middle-income countries.
Colombia is a country of unique advances and setbacks. In May, 2015, the Ministry of Health banned the use of glyphosate for the eradication of coca and poppy crops, after 34 years of use in jungle territories inhabited by vulnerable populations.1 The decision to ban glyphosate was debated by both scientists and politicians, and, in the interest of public health, this precautionary measure was applied after the International Agency for Research on Cancer concluded that glyphosate is potentially carcinogenic for humans.
We note with interest that The Lancet has begun a trial of preprint submissions (June 23, p 2482).1 At the Science Media Centre we appreciate the potential benefits of preprint to the research process, but we are concerned about possible unforeseen effects on the public’s understanding of science.
The first licences permitting mitochondrial donation were issued in late 2017 by the Human UK Fertilization and Embryo Authority (HFEA), the statutory authority charged with regulating human embryo research, representing a historic landmark in the quest to eradicate transmission of serious mitochondrial DNA (mtDNA) disease.1 We previously estimated2 the average number of births per year among women at risk for transmitting mtDNA disease to be 152 (95% CI 125–200) in the UK and 778 (636–944) in the USA; mitochondrial donation will have an immediate and direct effect on these births.
As I watched Paywall: The Business of Scholarship, I was taken back 30 years to when I thought for the first time about the business aspects of academic publishing. I was an assistant editor at the BMJ, and the editor asked me to join a meeting with a group of rheumatologists who wanted a share in the Annals of Rheumatic Diseases, a journal we owned. “We do the research published in the journal”, said one of the rheumatologists. “We do the peer review, we edit the journal, we read it, and we store it in our libraries.
As the son of a nurse and an engineer, Craig Anderson, Executive Director of The George Institute for Global Health in China and Professor of Neurology and Epidemiology at Australia’s University of New South Wales, always knew he was destined for a career in science. “I’ve got the health-care provider—some degree of benevolence, wanting to help people—and I’ve got a problem solving, analytical, methodological approach to wanting to understand and find solutions to things”, he says.
BY AMA SECRETARY-GENERAL DR MICHAEL SCHAPER
It’s a great pleasure to take up the role as your new national Secretary-General.
The SG’s role is pretty straight forward: to ensure that the machinery of the national secretariat is working efficiently and effectively, supporting our elected officebearers in their role as the national public face of the profession, and helping the different State and Territory AMAs in their work.
Advocacy and public campaigning is central to the work of the AMA, and to do this well we need to have a sophisticated team of policy personnel, media experts and administrators backing them up.
Doctors and the members of the broader medical community continue to be rated by Australians as one of – if not the – most trusted professions in the country. Medicine matters to everyone. It affects us all, and we need to ensure that Governments always keep this at the centre of their decision-making.
We will continue being active advocates for the sector. AMA members need to be getting value for money, they need to be kept informed of our policy debates and have the chance to contribute to them. We need as many doctors as possible to join, and to get involved.
The federal structure of the organisation needs to be respected and supported, so that local AMAs can also deal with local issues. We also have some great staff working in the Canberra office on your behalf, and I’m keen to attract other high-calibre recruits to join us when vacancies emerge.
Finally, we have to manage the finances of the organisation carefully, and ensure that member funds – your funds – are spent effectively. These are some of the early priorities I’ll be working on.
Previous office-bearers in this position have come from a wide variety of different walks of life: while originally most Secretaries-General were doctors, over the last 30 years the reach has expanded to include lawyers, ministerial advisers, health sector administrators, and a range of others.
My own background is also similarly diverse, with experience in small business advocacy, senior government administration, politics, academia, professional associations and national regulation. (Incidentally, that’s where the “Dr” title comes from – a PhD based on research into some professional practice management issues in the allied health sector.)
Finally, I hope also to be able to get out and meet as many members and local office-bearers as possible. A national organisation has its membership spread right over the country, and I’ll be working with our President to ensure that we both get to meet with, and hear the concerns of, AMA cardholders across Australia.
After all, it’s your organisation, and we’re here to serve you.
BY DR SANDRA HIROWATARI, CHAIR, AMA COUNCIL OF RURAL DOCTORS
What do you do when a patient or colleague asks you to do something that goes against your beliefs and principles?
It depends on the request and the strength of your conviction. A common example is termination of pregnancies – not a problem if you are all for it, quite a conundrum if you object on moral or religious grounds and cannot see yourself ever performing an abortion or even referring on to a colleague who does.
This would be a lose-lose situation – damned if you do, damned if you don’t. It is important to remember that you have rights and so does the patient. But will your rights or the patient’s rights be stepped on? The ideal outcome is that both the needs of the patient and the doctor are met.
In the urban setting, alternatives are available. You can make a direct or indirect referral. There are specialists in the Yellow Pages, and sexual health centres take calls, so indirectly you could respectfully refer the patient to do her own research. You could refer her to another GP colleague down the hall who does not have the same objection. This process keeps you one step removed from the act you conscientiously object to. Or, if you are comfortable, you can make a direct referral. This second type of referral takes you closer to the final termination. However you do this, your patient receives the care they need and you have not performed any actions contrary to your beliefs.
In the rural settings our options are not as broad. Often, we are the only medical resource; the timing of the pre-procedural investigations depend on us. We may need to sign the Patient Assisted Travel form that will ultimately lead to a medical act that we morally object to. We need to do the research to find the nearest provider. If you refuse, the patient meets hardship, and may have to travel far away to meet with another GP who may also have the same conscientious objection.
Time is of the essence. They are bewildered and stressed and so are you.
Can you be forced?
The Medical Board of Australia states we must not impede. Your actions cannot prevent the patient from getting the care she wishes. Our Association, the AMA, states that we need to inform the patient she can receive care elsewhere. Both organisations advocate transparency so that the patients and impacted doctors are aware of our stance.
Minor examples exist, such as a doctor who does not prescribe oral contraceptive pills, or doctors who refuse to do pap smears. This objection is not just preference or distaste, it is a deep seated religious or moral objection. In the city it is no big deal, alternative care is easily found elsewhere. Rurally, it is a big deal for a patient to have to travel to receive such routine medical care.
Another example, medically assisted dying, is just around the corner. When the legislation passes, of course you cannot be forced into action. However, what happens if you are the only doctor in a rural setting, and you DO believe in assisted euthanasia? The unintended consequence of your beliefs may cause your patients to feel uneasy and as such they may wish to get their care elsewhere. Unfortunately for many patients in rural and remote regions of Australia, there is often not much choice of doctors. This scenario has been already occurring in Canada.
Rural doctor, you know your own moral beliefs, you also know whether they deviate from the majority belief.
So arm yourself.
Find a pathway that will enshrine your needs while ensuring that rural patients receive the appropriate care. Prepare a phone list of known doctors you respect, who may or may not do as the patient wishes; find doctors who will help you keep your distance from the resulting consultation; offer telephone or telehealth consultations. The best thing you can do is get support before you need help with these difficult moral and ethical decisions.